Epithelial-to-mesenchymal transition correlates with gefitinib resistance in NSCLC cells and the liver X receptor ligand GW3965 reverses gefitinib resistance through inhibition of vimentin
Yong Hu,1,* Jialan Zang,2,* Xiaobing Qin,1 Dali Yan,1 Haixia Cao,1 Leilei Zhou,1 Jie Ni,1 Shaorong Yu,1 Jianzhong Wu,1 Ji-Feng Feng1 1Research Center for Clinical Oncology, Affiliated Cancer Hospital of Nanjing Medical University, Jiangsu Cancer Hospital and Jiangsu Institute of Cancer Research, Na...
| Main Authors: | , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2017-04-01
|
| Series: | OncoTargets and Therapy |
| Subjects: | |
| Online Access: | https://www.dovepress.com/epithelial-to-mesenchymal-transition-correlates-with-gefitinib-resista-peer-reviewed-article-OTT |